We found that the sensitivity of CTCs and a combination of tumor markers (CEA, CA 125, CYFRA 21‐1, and SCC) for lung cancer diagnosis to be 68.29% (AUCROC = 0.849) and 63.41% (AUCROC = 0.715), respectively. This evidence concerns the gene CEACAM5 and neoplasm.